Fig. 1.

Kaplan–Meier estimates of the cumulative incidence of linezolid—induced thrombocytopenia in patients with shock and patients without shock. a Criterion-1thrombocytopenia: thrombocytopenia with platelet count < 100 × 10⁹/L and a decrease in 25% or more from baseline of the platelet count; b Criterion-2 thrombocytopenia: thrombocytopenia due to a platelet count drop decrease of 25% or more from baseline; c Early-onset criterion-1 thrombocytopenia: criterion-1 thrombocytopenia occurrence within 6 days of linezolid treatment initiation; d Early-onset criterion-2 thrombocytopenia: criterion-2 thrombocytopenia occurrence within 6 days of initiating linezolid therapy